[go: up one dir, main page]

WO1998016265B1 - Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse - Google Patents

Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse

Info

Publication number
WO1998016265B1
WO1998016265B1 PCT/US1997/018582 US9718582W WO9816265B1 WO 1998016265 B1 WO1998016265 B1 WO 1998016265B1 US 9718582 W US9718582 W US 9718582W WO 9816265 B1 WO9816265 B1 WO 9816265B1
Authority
WO
WIPO (PCT)
Prior art keywords
occludant
new
precursor composition
partially hydrolyzed
radio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/018582
Other languages
English (en)
Other versions
WO1998016265A1 (fr
Filing date
Publication date
Priority claimed from US08/734,442 external-priority patent/US5925683A/en
Application filed filed Critical
Priority to DE69735534T priority Critical patent/DE69735534T2/de
Priority to EP97912731A priority patent/EP0934086B1/fr
Priority to AU49842/97A priority patent/AU4984297A/en
Priority to JP51855298A priority patent/JP3804071B2/ja
Publication of WO1998016265A1 publication Critical patent/WO1998016265A1/fr
Publication of WO1998016265B1 publication Critical patent/WO1998016265B1/fr
Priority to US09/291,853 priority patent/US6160025A/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Abstract

L'invention porte sur une composition de matières comportant des solutions partiellement hydrolysées d'acétate de polyvinyle pouvant servir de précurseur d'un agent embolisant. L'invention porte également sur une procédure d'introduction de solutions dans le corps humain pour former par précipitation des blocs d'occlusion embolisants. Elle porte en outre sur une procédure de traitement des tumeurs hépatiques par embolisation de la veine porte.
PCT/US1997/018582 1996-10-17 1997-10-15 Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse Ceased WO1998016265A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE69735534T DE69735534T2 (de) 1996-10-17 1997-10-15 Flüssige embolisationsmittel aus teilweise hydrolysiertem polyvinylacetat
EP97912731A EP0934086B1 (fr) 1996-10-17 1997-10-15 Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse
AU49842/97A AU4984297A (en) 1996-10-17 1997-10-15 Liquid embolic agents containing partially hydrolyzed polyvinyl acetate
JP51855298A JP3804071B2 (ja) 1996-10-17 1997-10-15 部分的に加水分解されたポリビニルアセテートを含有する液体塞栓剤
US09/291,853 US6160025A (en) 1996-10-17 1999-04-14 Liquid embolic agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/734,442 1996-10-17
US08/734,442 US5925683A (en) 1996-10-17 1996-10-17 Liquid embolic agents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US08/734,442 Continuation-In-Part US5925683A (en) 1996-10-17 1996-10-17 Liquid embolic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/291,853 Continuation US6160025A (en) 1996-10-17 1999-04-14 Liquid embolic agents

Publications (2)

Publication Number Publication Date
WO1998016265A1 WO1998016265A1 (fr) 1998-04-23
WO1998016265B1 true WO1998016265B1 (fr) 1998-06-18

Family

ID=24951721

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/018582 Ceased WO1998016265A1 (fr) 1996-10-17 1997-10-15 Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse

Country Status (6)

Country Link
US (2) US5925683A (fr)
EP (1) EP0934086B1 (fr)
JP (1) JP3804071B2 (fr)
AU (1) AU4984297A (fr)
DE (1) DE69735534T2 (fr)
WO (1) WO1998016265A1 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69834920T2 (de) 1997-08-05 2007-05-24 Boston Scientific Ltd., St. Michael Ablösbares system zum verschliessen eines aneurysmashalses
US6063070A (en) 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US6146373A (en) * 1997-10-17 2000-11-14 Micro Therapeutics, Inc. Catheter system and method for injection of a liquid embolic composition and a solidification agent
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
WO2000013593A1 (fr) 1998-09-04 2000-03-16 Boston Scientific Limited (Incorporated In Ireland) Piece de fermeture detachable pour collet anevrysmal
FR2784580B1 (fr) 1998-10-16 2004-06-25 Biosepra Inc Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
WO2001003666A2 (fr) * 1999-07-12 2001-01-18 Scimed Life Systems, Inc. Compositions pour occlusion vasculaire a base de liquide
US6346098B1 (en) 2000-03-07 2002-02-12 The Board Of Trustees Of The Leland Stanford Junior University Methods and kits for locally administering an active agent to an interstitial space of a host
US6676971B2 (en) * 2000-03-13 2004-01-13 Biocure, Inc. Embolic compositions
KR100872884B1 (ko) 2000-03-24 2008-12-10 바이오스피어 메디칼 인코포레이티드 능동 색전화용 미소구
US20030212022A1 (en) * 2001-03-23 2003-11-13 Jean-Marie Vogel Compositions and methods for gene therapy
US6729356B1 (en) 2000-04-27 2004-05-04 Endovascular Technologies, Inc. Endovascular graft for providing a seal with vasculature
US6658288B1 (en) 2000-05-05 2003-12-02 Endovascular Technologies, Inc. Apparatus and method for aiding thrombosis through the application of electric potential
WO2002009789A2 (fr) * 2000-08-02 2002-02-07 Aesculap Ag & Co. Kg Produit technique medical, son procede de production et de preparation pour la chirurgie
DE10117099A1 (de) * 2000-08-02 2002-02-21 Aesculap Ag & Co Kg Medizintechnisches Produkt, Verfahren zu seiner Herstellung und Bereitstellung für die Chirurgie
JP2004527311A (ja) * 2001-04-26 2004-09-09 ポーター、クリストファー、エイチ． 体内に材料を送達する方法及び装置
WO2002089676A2 (fr) * 2001-05-04 2002-11-14 Concentric Medical Dispositif pour occlusion vasculaire a filament hydrogel
US20020193812A1 (en) * 2001-05-04 2002-12-19 Concentric Medical Hydrogel vaso-occlusive device
US20030004568A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Coated combination vaso-occlusive device
US6685745B2 (en) * 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
US7687053B2 (en) * 2001-08-20 2010-03-30 Boston Scientific Scimed, Inc. Embolic compositions with non-cyanoacrylate rheology modifying agents
US20030050635A1 (en) * 2001-08-22 2003-03-13 Csaba Truckai Embolization systems and techniques for treating tumors
US6911219B2 (en) * 2001-09-27 2005-06-28 Surgica Corporation Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them
WO2003037191A1 (fr) * 2001-10-26 2003-05-08 Concentric Medical Dispositif destine a une occlusion vasculaire
US7341716B2 (en) * 2002-04-12 2008-03-11 Boston Scientific Scimed, Inc. Occlusive composition
EP1559440B1 (fr) * 2002-10-29 2015-09-23 Toray Industries, Inc. Materiau d'embolisation vasculaire
HUP0203719A2 (en) * 2002-10-31 2007-09-28 Stepan Dr Gudak Polyuretan composition for fillin blood vessels and method of aplication of it
US20040115164A1 (en) * 2002-12-17 2004-06-17 Pierce Ryan K. Soft filament occlusive device delivery system
ATE429940T1 (de) * 2003-03-07 2009-05-15 Micro Therapeutics Inc Zusammensetzungen enthaltend hohe konzentration von kontrastmittel zur embolisierung von blutgefassen
US20050209674A1 (en) * 2003-09-05 2005-09-22 Kutscher Tuvia D Balloon assembly (V)
US20050090804A1 (en) * 2003-10-22 2005-04-28 Trivascular, Inc. Endoluminal prosthesis endoleak management
US20050283182A1 (en) * 2004-06-21 2005-12-22 Concentric Medical, Inc. Systems and methods for intraluminal delivery of occlusive elements
EP2484344B1 (fr) * 2005-05-09 2016-02-10 Biosphere Medical, S.A. Compositions et procédés pour utiliser des microsphères et des agents de contraste non ioniques
WO2007047851A2 (fr) * 2005-10-19 2007-04-26 Pulsar Vascular, Inc. Procedes et systemes d'agrafage et de reparation par voie endovasculaire d'anomalies dans des lumieres ou des tissus
US8545530B2 (en) * 2005-10-19 2013-10-01 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
EP1986707A2 (fr) * 2006-01-30 2008-11-05 Surgica Corporation Particules d'embolisation intravasculaire compressible, procedes connexes et systemes d'administration
WO2007090130A2 (fr) * 2006-01-30 2007-08-09 Surgica Corporation Particules d'embolisation intravasculaire et procedes associes
WO2007131223A2 (fr) * 2006-05-05 2007-11-15 Freleng Safety Products, Llc Marqueur de visibilité personnel
US9717584B2 (en) * 2007-04-13 2017-08-01 W. L. Gore & Associates, Inc. Medical apparatus and method of making the same
US20080255678A1 (en) * 2007-04-13 2008-10-16 Cully Edward H Medical apparatus and method of making the same
US9642693B2 (en) * 2007-04-13 2017-05-09 W. L. Gore & Associates, Inc. Medical apparatus and method of making the same
CA2736251C (fr) 2008-09-05 2017-11-28 Pulsar Vascular, Inc. Systemes et procedes pour soutenir ou fermer une ouverture ou cavite physiologique
US20110212179A1 (en) * 2008-10-30 2011-09-01 David Liu Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
ES2922979T3 (es) 2009-09-04 2022-09-22 Pulsar Vascular Inc Sistemas para encerrar una abertura anatómica
JP6563192B2 (ja) 2011-06-03 2019-08-21 パルサー バスキュラー インコーポレイテッド 動脈瘤装置と動脈瘤治療システム
JP6219270B2 (ja) 2011-06-03 2017-10-25 パルサー バスキュラー インコーポレイテッド 動脈瘤装置
EP3738527A1 (fr) 2011-10-05 2020-11-18 Pulsar Vascular, Inc. Dispositifs de fermeture d'une ouverture anatomique
EP2846706A1 (fr) 2012-05-10 2015-03-18 Pulsar Vascular, Inc. Dispositifs d'anévrisme à extrémité spirale
CN102764456B (zh) * 2012-07-24 2014-10-15 上海交通大学 血管栓塞剂及其用途、制备方法
CN111840265B (zh) * 2019-04-29 2023-06-16 李学义 一种乙醇类硬化剂及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2160503A (en) * 1936-02-14 1939-05-30 Chemische Forschungs Gmbh Blood stancher
US2657201A (en) * 1949-11-25 1953-10-27 Du Pont Controlled, heterogeneous hydrolysis of polymeric esters
SE392100B (sv) * 1969-06-27 1977-03-14 Nyegaard & Co As Trijodbensoylaminer till anvendning sasom rontgenkontrastmedel eller for separation av biologiska material
DE2909439A1 (de) * 1979-03-08 1980-09-18 Schering Ag Neue nichtionische roentgenkontrastmittel
US4631188A (en) * 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4739768B2 (en) * 1986-06-02 1995-10-24 Target Therapeutics Inc Catheter for guide-wire tracking
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
ATE130517T1 (de) * 1990-08-08 1995-12-15 Takeda Chemical Industries Ltd Intravaskulär embolisierendes mittel mit gehalt an einem die angiogenesis hemmenden stoff.
US5690666A (en) * 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5443454A (en) * 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
WO1996004954A1 (fr) * 1994-08-17 1996-02-22 Boston Scientific Corporation Implant, et procede et dispositf d'implantation
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels

Similar Documents

Publication Publication Date Title
WO1998016265B1 (fr) Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse
CA2060652A1 (fr) Derives a groupe n-(substituant) cycloalkyl et polycycloalkyl trp-, phe- et phenethylamine, substitue en alpha
US4054736A (en) Clathrate compounds of prostaglandins or their analogues with cyclodextrin
WO1996032419B1 (fr) Polymeres de polyacetals biodegradables, formation et utilisation
CA2198917A1 (fr) Liberation prolongee de peptides depuis des compositions pharmaceutiques
CH619614A5 (fr)
CH629475A5 (de) Verfahren zur herstellung von polypeptiden.
DE59010706D1 (de) Gallensäurederivate, Verfahren zu ihrer Herstellung, Verwendung als Arzneimittel
CA2212856A1 (fr) Composes contenant du benzopyranne et techniques d'application
DE3481170D1 (de) Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung.
TW329386B (en) Cough medicine
IE881017L (en) Novel 2ß-morpholino-androstane derivatives and processes for¹their preparation
HUT64518A (en) Process for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
CA2085469A1 (fr) Polypeptides hydrosolubles ayant une haute affinite pour les interferons .alpha. et .beta.
Chatt et al. Chemical evidence concerning the function of molybdenum in nitrogenase
CA2381461A1 (fr) Antagonistes de l'hormone de liberation de l'hormone luteinisante (lhrh) ayant des proprietes de dissolution ameliorees
DE69829880T2 (de) Konjugate enthaltend zwei wirkstoffe
WO1996001634B1 (fr) Compositions a base d'oxytretracycline a action prolongee
DE69001734T2 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
Colonna et al. Large scale HELP synthesis of oligodeoxynucleotides by the hydroxybenzotriazole phosphotriester approach.
EP0383346A3 (fr) Catalyseur, procédé pour le préparer et procédé de polymérisation d'oléfines utilisant ce catalyseur
CA2249753A1 (fr) Procede ameliore de synthese d'alkyl-polyglucosides
WO2001032680A3 (fr) 18-nor-steroides utilises comme oestrogenes a effet selectif
WO1999005103A3 (fr) Derives d'amidino-camptothecine
ATE30231T1 (de) 3-beta-(3'-(carboxypropionyloxy))-ursa-9(11),12 dien-28-carbonsaeure sowie ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.